Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced
Latest available record · 8 Oct 2026

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 31 May 2026
Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.
1733not yet publishedAug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26

Scope · likely financings by canton

38 likely financings · 2 May 2026 – 31 May 2026 · the feed below shows one weekClick a canton to filter the feedMap: Natural Earth

Likely financing
Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided
Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased
No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round
A financing announcement on startupticker.ch names the company and matches this increase.

Published 25–31 May 2026

39 capital increases · 8 shown
Showing: likely financings and confirmed rounds ▾
Show
Capital increases published 25–31 May 2026
CompanyStatusNominal share capital (CHF)
before → after		New shares, % of
post-step shares		Announced roundnot disclosed in the SHABSHAB publishedSource
Specto Medical AGBS · Die Gesellschaft bezweckt die Entwicklung und Lizenzierung von sowie den Vertrieb und Handel mit …SHAB publication HR02-1006662242Likely financingscore 0.72320’000 → 430’000New shares 25.6%25.6%—29 May 2026SHAB publication HR02-1006662242
Malaica AGZH · Die Gesellschaft bezweckt die Entwicklung von sowie den Handel mit Produkten im Bereich des …SHAB publication HR02-1006661680Likely financingscore 0.80134’199.10 → 141’685.70New shares 5.3%5.3%—29 May 2026SHAB publication HR02-1006661680
On Venture Studio SAVD · la Société a pour but toutes activités de développement et fourniture de solutions complètes, notamment des …SHAB publication HR02-1006661333Likely financingscore 0.72100’000 → 118’628.89New shares — share counts not published— share counts not published—28 May 2026SHAB publication HR02-1006661333
HELVO SAVD · la Société a pour but, en Suisse et/ou à l'étranger, de fournir des services dans le domaine du traitement …SHAB publication HR02-1006661315Likely financingscore 0.90500’000 → 869’749.37New shares — nominal value per share changed— nominal value per share changed—28 May 2026SHAB publication HR02-1006661315
Swiss Blue Salmon AGGL · Die Gesellschaft bezweckt den Bau und den Betrieb von Lachszuchten, den Verkauf und die Vermarktung der …SHAB publication HR02-1006660751Likely financingscore 0.66222’110 → 282’710New shares 21.4%21.4%—28 May 2026SHAB publication HR02-1006660751
Planetary SAGE · La société a pour but la production à l'échelle industrielle de protéines alternatives en utilisant des …SHAB publication HR02-1006660326Likely financing · possible confirmationscore 0.90129’651.60 → 181’579.20New shares 28.6%28.6%—27 May 2026SHAB publication HR02-1006660326
CCRAFT SANE · La société a pour but la fabrication de puces électroniques et la prestation de services y afférents. La …SHAB publication HR02-1006660206Confirmed roundscore 0.93Announced round: Announced ↗100’000 → 121’999.80New shares 18.0%18.0%Announced ↗27 May 2026SHAB publication HR02-1006660206
aevX Bio SAZH · Die Gesellschaft bezweckt die Forschung, Entwicklung, Herstellung und Vermarktung von Produkten, Verfahren …SHAB publication HR02-1006659167Likely financingscore 0.96100’000 → 117’600New shares 15.0%15.0%—27 May 2026SHAB publication HR02-1006659167

31 other capital increases published this week ▸